Navigation Links
DUSA Pharmaceuticals to Present at Roth Capital Partners 22nd Annual OC Growth Stock Conference
Date:3/9/2010

WILMINGTON, Mass., March 9 /PRNewswire-FirstCall/ -- DUSA Pharmaceuticals, Inc.®  (Nasdaq: DUSA), a specialty pharmaceutical company focused primarily on the development and marketing of its Levulan® Photodynamic Therapy (PDT) technology platform for the prevention and treatment of dermatological skin conditions, announced that Bob Doman, President and Chief Executive Officer, will present a corporate overview at the Roth 22nd Annual OC Growth Stock Conference.  The conference is being held at the Ritz-Carlton Laguna Niguel, Dana Point, California on March 15-17, 2010.  Mr. Doman is scheduled to present at 12:00 p.m. Pacific Time (3:00 p.m. Eastern Time) on March 16, 2010.  Interested parties can access the live audio webcast of the presentation at www.dusapharma.com. An archived version of the presentation will be available on the DUSA website approximately three hours following the presentation.

About DUSA Pharmaceuticals

DUSA Pharmaceuticals, Inc. is an integrated dermatology pharmaceutical company focused primarily on the development and marketing of its Levulan® photodynamic therapy (PDT) technology platform, and complementary dermatology products.  Levulan® PDT is currently approved for the treatment of Grade 1 and 2 actinic keratoses of the face and scalp.  DUSA also markets other dermatology products, including ClindaReach®.  DUSA is researching the use of broad area Levulan® PDT to treat AKs and prevent squamous cell carcinomas in immunosuppressed solid organ transplant recipients and is supporting research related to oral leukoplakia in collaboration with the National Institutes of Health (NIH).  DUSA is based in Wilmington, Mass.  Please visit our website at www.dusapharma.com.

SOURCE DUSA Pharmaceuticals, Inc.

Back to top

RELATED LINKS
http://www.dusapharma.com

'/>"/>

SOURCE DUSA Pharmaceuticals, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Related medicine technology :

1. ISTA Pharmaceuticals Receives Action Date for FDA Review of Once-Daily XiDay(TM)
2. Ampio Pharmaceuticals, Inc. Retains Redwood Consultants, LLC to Assist in Shareholder Relations and Strategic Planning
3. Charles E. Lannon Was Appointed as Vice-Chairman of the Board of Directors at Kinex Pharmaceuticals
4. Chay Enterprises Inc. Completes Merger With Repurposed Drug Developer Ampio Pharmaceuticals, Inc.
5. Jazz Pharmaceuticals, Inc. Announces Fourth Quarter and Full Year 2009 Financial Results
6. Shionogi Enters Into Exclusive License Agreement With QuatRx Pharmaceuticals To Market Ospemifene
7. Isis Pharmaceuticals to Present at the Cowen and Company 30th Annual Health Care Conference
8. Anadys Pharmaceuticals to Present at the Cowen and Company Healthcare Conference
9. Savient Pharmaceuticals Reports Fourth Quarter and Year-End 2009 Financial Results
10. Vanda Pharmaceuticals Announces U.S. Patent Allowance for a Long-Acting Injectable Formulation of Fanapt(TM) (iloperidone) in the U.S.
11. Idenix Pharmaceuticals Reports Fourth Quarter and Year End 2009 Financial Results
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/17/2017)... Conn. , Feb. 17, 2017 Arvinas ... of drugs based on protein degradation, today announced the ... receptor (AR) PROTAC during a poster session at the ... (ASCO GU) in Orlando, FL. ... to validate our platform and the potential of PROTACs ...
(Date:2/17/2017)... and Markets has announced the addition of the "Drug-Eluting Stents - ... ... US, Canada , Japan , ... America , and Rest of World. Annual estimates and forecasts are ... is provided for these markets. Market data and analytics are derived from ...
(Date:2/17/2017)... , Feb. 17, 2017 ... health offerings at the  2017 HIMSS ... PHG,AEX: PHIA), a global leader ... broad range of population health ... health solutions, fully integrated in a highly ...
Breaking Medicine Technology:
(Date:2/20/2017)... PA (PRWEB) , ... February 20, 2017 , ... ... collaborating to help health care providers better manage patient health risks, foster behavior change ... medication video library in the world, will present a demonstration of its video capability ...
(Date:2/20/2017)... ... February 20, 2017 , ... ReportingMD, a Population Health Software Company, is pleased to announce ... The new location will triple the size of the previous location while bringing life ... Sunapee, NH. , “We are excited to expand our footprint to better serve ...
(Date:2/20/2017)... , ... February 20, 2017 , ... ... care providers and health plan partners, announced during the 2017 Annual HIMSS ... enhancing care coordination for diabetic patients and integrating eye care into mainstream ...
(Date:2/19/2017)... , ... February 19, 2017 , ... ProBrand Glitch is a set of 30 glitch ... Glitch users can easily reveal any logo with a glitch reveal in just a few ... over the style and animation of each preset. Use these presets to add a uniquely ...
(Date:2/18/2017)... ... February 17, 2017 , ... ... of disruptive innovation in the industry, according to the recent NEJM Catalyst Insights ... on surveys of the NEJM Catalyst Insights Council, a qualified group of U.S. ...
Breaking Medicine News(10 mins):